These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Design, synthesis, and antitumor activity of novel podophyllotoxin derivatives as potent anticancer agents. Liu J; Cao B; Gao Y; Bai M; Mei X; Chen H; Jiang YG; Huang DJ J Asian Nat Prod Res; 2013 Sep; 15(9):985-92. PubMed ID: 23859462 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticancer activity of dimeric podophyllotoxin derivatives. Zi CT; Yang L; Xu FQ; Dong FW; Yang D; Li Y; Ding ZT; Zhou J; Jiang ZH; Hu JM Drug Des Devel Ther; 2018; 12():3393-3406. PubMed ID: 30349193 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor activity of novel podophyllotoxin derivatives against multidrug-resistant cancer cells. Guo YE; Chen H; Zuo S; Liu DL; Lu YL; Lv JJ; Wen SP; Zhang TC J Asian Nat Prod Res; 2011 May; 13(5):417-24. PubMed ID: 21534039 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of 4α/4β-imidazolyl podophyllotoxin analogues as antitumor agents. Shang H; Chen H; Zhao D; Tang X; Liu Y; Pan L; Cheng M Arch Pharm (Weinheim); 2012 Jan; 345(1):43-8. PubMed ID: 21956645 [TBL] [Abstract][Full Text] [Related]
6. 4-Aza-2,3-dehydro-4-deoxypodophyllotoxins: simple aza-podophyllotoxin analogues possessing potent cytotoxicity. Hitotsuyanagi Y; Fukuyo M; Tsuda K; Kobayashi M; Ozeki A; Itokawa H; Takeya K Bioorg Med Chem Lett; 2000 Feb; 10(4):315-7. PubMed ID: 10714489 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of novel spin-labeled derivatives of podophyllotoxin as potential antineoplastic agents. Part XII. Yang L; Liu YQ; Tan H; Li WG; Tian X Nat Prod Res; 2007 Sep; 21(11):998-1008. PubMed ID: 17691049 [TBL] [Abstract][Full Text] [Related]
8. 4'-Demethyl-deoxypodophyllotoxin glucoside isolated from Podophyllum hexandrum exhibits potential anticancer activities by altering Chk-2 signaling pathway in MCF-7 breast cancer cells. Zilla MK; Nayak D; Amin H; Nalli Y; Rah B; Chakraborty S; Kitchlu S; Goswami A; Ali A Chem Biol Interact; 2014 Dec; 224():100-7. PubMed ID: 25446499 [TBL] [Abstract][Full Text] [Related]
9. [Synthesis and activities of 4-deoxy-4 beta-arylmehtylene sulfonylamido-4'-demethylpodophyllotoxins]. He Y; Ma WY; Chen XH; Zhang CN Yao Xue Xue Bao; 2001 Feb; 36(2):105-7. PubMed ID: 12579874 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and comparative evaluation of 4-oxa- and 4-aza-podophyllotoxins as antiproliferative microtubule destabilizing agents. Chernysheva NB; Tsyganov DV; Philchenkov AA; Zavelevich MP; Kiselyov AS; Semenov RV; Semenova MN; Semenov VV Bioorg Med Chem Lett; 2012 Apr; 22(7):2590-3. PubMed ID: 22370267 [TBL] [Abstract][Full Text] [Related]
11. Sesquiterpenoids and cytotoxic lignans from the bark of Libocedrus chevalieri. Zhang YJ; Litaudon M; Bousserouel H; Martin MT; Thoison O; Léonce S; Dumontet V; Sévenet T; Guéritte F J Nat Prod; 2007 Aug; 70(8):1368-70. PubMed ID: 17676899 [TBL] [Abstract][Full Text] [Related]
12. Recent developments towards podophyllotoxin congeners as potential apoptosis inducers. Kamal A; Hussaini SM; Malik MS Anticancer Agents Med Chem; 2015; 15(5):565-74. PubMed ID: 25469512 [TBL] [Abstract][Full Text] [Related]
13. [A multivariate analysis approach to antineoplastic and antiviral structure-activity relationships to a series of podophyllotoxins]. Doré JC; Viel C; Pageot N; Gordaliza M; Castro A; del Corral JM; Feliciano AS J Pharm Belg; 1996; 51(1):9-18. PubMed ID: 8882445 [TBL] [Abstract][Full Text] [Related]
14. Synthetic and application perspectives of azapodophyllotoxins: alternative scaffolds of podophyllotoxin. Kumar A; Kumar V; Alegria AE; Malhotra SV Curr Med Chem; 2011; 18(25):3853-70. PubMed ID: 21824101 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxicity of racemic isodeoxypodophyllotoxin analogues with isoprene-derived side chains. Zhao Y; Feng JH; Ding HX; Xiong Y; Cheng CH; Hao XJ; Zhang YM; Pan YJ; Guéritte F; Wu XM; Bai H; Stöckigt J J Nat Prod; 2006 Aug; 69(8):1145-52. PubMed ID: 16933865 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents. Reddy PB; Agrawal SK; Singh S; Bhat BA; Saxena AK; Kumar HM; Qazi GN Chem Biodivers; 2008 Sep; 5(9):1792-802. PubMed ID: 18816530 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in semisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: an update (2008-2010). Lv M; Xu H Mini Rev Med Chem; 2011 Sep; 11(10):901-9. PubMed ID: 21781026 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents. Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of podophyllotoxin congeners as tubulin polymerization inhibitors. Kamal A; Srinivasa Reddy T; Polepalli S; Shalini N; Reddy VG; Subba Rao AV; Jain N; Shankaraiah N Bioorg Med Chem; 2014 Oct; 22(19):5466-75. PubMed ID: 25131956 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic lignans from fruits of Cleistanthus indochinensis: synthesis of cleistantoxin derivatives. Thanh VT; Pham VC; Mai HD; Litaudon M; Guéritte F; Retailleau P; Nguyen VH; Chau VM J Nat Prod; 2012 Sep; 75(9):1578-83. PubMed ID: 22938151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]